Adherence therapy for schizophrenia: a randomised
controlled trial
WT Chien1, EFC Cheung2, JHC
Mui2, R Gray3, G Ip4
1 Nethersole School of Nursing, The
Chinese University of Hong Kong
2 Castle Peak Hospital, Hospital
Authority, Hong Kong
3 Faculty of Medicine & Health
Sciences, University of East Anglia, United Kingdom
4 Kwai Chung Hospital, Hospital
Authority, Hong Kong
1. Compared with routine care, adherence therapy is
an effective alternative for people with schizophrenia with poor
medication adherence and short duration of illness.
2. Adherence therapy can significantly improve patient adherence to antipsychotic medication, insight into illness/treatment, and re-hospitalisation rate, as well as psychotic symptoms and functioning over 12-month follow-up.
3. Adherence therapy can be cost-effective over the 12-month follow-up.
2. Adherence therapy can significantly improve patient adherence to antipsychotic medication, insight into illness/treatment, and re-hospitalisation rate, as well as psychotic symptoms and functioning over 12-month follow-up.
3. Adherence therapy can be cost-effective over the 12-month follow-up.